Helen. B. Taussig- American cardiologist

Federal State Budget Educational Establishment

Of Higher Education

<<Penza State University>>

Medical Institute

Course Paper

In History

<<Helen B. Taussig(1898- 1986) >>

Student: Modi Anuj

Group: 19ll6A

Instructor: Dr. Gavrilova Tatiana

 

 

PENZA 2019-20

Contents:

Introduction

Banning of thalidomide

Founded field of paediatric cardiology

First surgeries

Further career

Achievements

Introduction:                              

                                       Helen B. Taussig (1898–1986)

Helen Brooke Taussig (May 24, 1898 – May 20, 1986) was an American cardiologist, working in Baltimore and Boston, who founded the field of pediatric cardiology. She is credited with developing the concept for a procedure that would extend the lives of children born with Tetralogy of Fallot (the most common cause of blue baby syndrome). This concept was

 

applied in practice as a procedure known as the Blalock-Thomas-Taussig shunt.

 The procedure was developed by Alfred Blalock and Vivien Thomas, who were Taussig's colleagues at the Johns Hopkins Hospital.Taussig was partially deaf following an ear infection in childhood; in early adulthood this progressed to full deafness.To compensate for her loss of hearing, she learned to use lip-reading techniques and hearing aids to speak with her patients. Taussing also developed a method of using her fingers, rather than a stethoscope, to feel the rhythm of their heartbeats. Some of her innovations have been attributed to her ability to diagnose heart problems by touch rather than by sound.

Taussig is also known for her work in banning thalidomide and was widely recognized as a highly-skilled physician. She was the first woman to be elected head of the American Heart Association, and in 1964 she was awarded a Presidential Medal of Freedom.

Banning of thalidomide :

Around 1960, many more babies than usual began to be born in Germany, Belgium and the Netherlands with phocomelia, a previously very rare condition in which limbs are absent or small and abnormally formed. The German paediatrician Widukind Lenz was the first to draw a link to the increasing frequency of this condition and thalidomide, a drug which was a popular sleeping medication at the time with the trade name Softenon, and was often taken by pregnant women to counter morning sickness. However, when it is taken between days 35 and 49 of a pregnancy, it blocks normal limb development and causes phocomelia.

After hearing about this issue from one of her students in January 1962, Taussig travelled to Germany and examined some of these children for

 

herself. She reached the same conclusion as Lenz: that thalidomide taken during pregnancy was causing phocomelia.

 She flew back to America and launched a campaign to try to stop the pending approval of thalidomide by the FDA, speaking at the American College of Physicians, writing in journals and magazines, and testifying before Congress in 1967. Her and others' efforts paid off: the drug was banned in the United States and Europe.

Founded field of paediatric cardiology:

Taussig's early career in pediatric cardiology at Johns Hopkins consisted of studying babies with congenital heart defects and rheumatic fever, an inflammation of the heart and other organs resulting from bacterial infection, which was at the time a major source of child mortality. In the early 20th century, rheumatic heart disease made up the majority of clinical cardiology work: congenital heart defects were considered hopeless curiosities as the surgical means to correct them were extremely undeveloped so relatively little could be done to prevent the early deaths of patients with these conditions.

She then was hired by the pediatric department of Johns Hopkins, the Harriet Lane Home, as its chief, where she served from 1930 until 1963. Taussig made use of fluoroscopy as a diagnostic tool, and developed a particular interest in infants with cyanosis (blue-tinged appearance), often caused by the heart defect Tetralogy of Fallot. Cyanosis is caused when insufficient oxygenated blood is circulating around the body; in infants it can be known as "blue baby syndrome".

 

Taussig is most remembered for her role in the development of a surgical treatment for this condition, the Blalock-Thomas-Taussig shunt.A new surgery first performed in 1939 by Robert Gross corrected a common pediatric heart problem: patent ductus arteriosus.

 The ductus arteriosus is a small blood vessel connecting the pulmonary artery to the aorta of a foetus. Since the foetus obtains oxygen via the mother's placenta and not via its own lungs, which are fluid-filled and not yet functional, this vessel provides a shortcut, bypassing the lungs and allowing more efficient delivery of oxygenated blood around the foetus' body. In most infants, the ductus arteriosus closes within a few weeks of birth so that blood flows to the lungs to be oxygenated; if it remains open or 'patent', the normal flow of blood is disrupted. This new surgical procedure artificially closed the blood vessel.

While this was going on, Taussig observed that infants with cyanotic heart defects such as Tetralogy of Fallot or pulmonary atresia often fared remarkably better if they also had a patent ductus arteriosus, with less severe symptoms and longer survival. In general, cyanotic symptoms would often begin or worsen shortly after birth, a change which Taussig suspected was caused by the natural closure of the ductus arteriosus. In cyanotic children, bloodflow from the heart to the lungs via the pulmonary artery is often compromised; Taussig thought that surgically creating an artificial ductus linking these two vessels could increase bloodflow to the lungs and alleviate this problem, increasing survival. She broached the idea to Robert Gross, and he was skeptical, reportedly telling her ". "I have enough trouble closing the ductus arteriosus. I certainly don’t want to try to make an artificial one."

First surgeries:

Taussig's early career in pediatric cardiology at Johns Hopkins consisted of studying babies with congenital heart defects and rheumatic fever,an inflammation of the heart and other organs resulting from bacterial infection, which was at the time a major source of child mortality.

In the early 20th century, rheumatic heart disease made up the majority of clinical cardiology work: congenital heart defects were considered hopeless curiosities as the surgical means to correct them were extremely undeveloped so relatively little could be done to prevent the early deaths of patients with these conditions.

She then was hired by the pediatric department of Johns Hopkins, the Harriet Lane Home, as its chief, where she served from 1930 until 1963. Taussig made use of fluoroscopy as a diagnostic tool, and developed a particular interest in infants with cyanosis (blue-tinged appearance), often caused by the heart defect Tetralogy of Fallot. Cyanosis is caused when insufficient oxygenated blood is circulating around the body; in infants it can be known as "blue baby syndrome". Taussig is most remembered for her role in the development of a surgical treatment for this condition, the Blalock-Thomas-Taussig shunt.

 

Further career:

As a physician, Taussig pioneered the use of x-rays and fluoroscopy simultaneously to examine changes in a baby's heart and lungs in a less invasive manner, and was very skilled in diagnosing heart conditions by feeling the heartbeat with her fingertips, rather than listening with a stethoscope.As well as her day to day clinical work as a paediatrician, Taussig was also an accomplished academic clinician. She published 100 academic articles over her career, considering various aspects of

 

cardiology including biomedical ethics and the evolutionary origins of heart disease. In her research into the long-term outcomes of recipients of the shunt, Taussig remained in touch with many of her patients as they grew to adulthood and middle age.

In 1947, after a decade of gathering material,Taussig published her magnum opus, Congenital Malformations of the Heart, to be the foundational text of pediatric cardiology as an independent field. The book was expanded into two volumes for a second edition published in 1960.Taussig later became an associate professor at the Johns Hopkins School of Medicine; she was promoted to full professor in 1959. At the time, she was only the second woman to reach full professor status at the university. She continued to serve as the director of the Harriet Lane Home (the children's treatment and research centre at Johns Hopkins) until her retirement in 1963. Most paediatric clinics at the time focussed on rheumatic fever, which was the major source of child mortality, but because of Taussig's experience, the Harriet Lane Home was also able to provide specialist care for children with congenital heart disease. It became a world-leading centre that aspiring surgeons flocked to.

Together with the cardiologist Richard Bing, Taussig was in 1949 the first to describe a heart condition now known as Taussig-Bing syndrome.This is the second most common type of double-outlet right ventricle (DORV),a set of rare congenital heart conditions in which the aorta, which is supposed to carry oxygen-rich blood from the left ventricle of the heart, instead is connected to the right ventricle and supplies oxygen-poor blood to the body. Several alternative methods for surgically correcting this defect have been tried over the decades since the problem was first described, and survival rates following surgical intervention are greatly improved in recent decades.

 

 

Helen. B. Taussig- American cardiologist

Achievements:

Throughout her career, Taussig earned more than 20 honorary degrees.Taussig was a member of several professional societies during her career. She was a member of the American Pediatric Society, the Society for Pediatric Research, and the American College of Physicians.

Like:

1947: Chevalier (knight) of the Legion d'Honneur.

1948: Passano Foundation Award for an outstanding contribution to medical science, shared with Alfred Blalock- the first time this award was shared, and the first time it was awarded to a woman

1953: Honorary medal from the American College of Chest Physicians

1954: Feltrinelli Award,and many more.

 


Дата добавления: 2021-11-30; просмотров: 17; Мы поможем в написании вашей работы!

Поделиться с друзьями:




Мы поможем в написании ваших работ!